Age(y), n (%) |
Age(y), n (%) |
|
|
0.847 |
≤45 |
33 (56.9) |
18 (58.1) |
15 (55.6) |
|
>45 |
25 (43.1) |
13 (41.9) |
12 (44.4) |
|
Stage, n (%) |
Stage, n (%) |
|
|
0.735 |
IA2-IB3 |
24 (41.4) |
12 (38.7) |
12 (44.4) |
|
IIA1-IIA2 |
18 (31.0) |
11 (35.5) |
7 (25.9) |
|
IIIC |
16 (27.6) |
8 (25.8) |
8 (29.6) |
|
Tumor size, n (%) |
Tumor size, n (%) |
|
|
0.766 |
≤4cm |
44 (75.9) |
24 (77.4) |
20 (74.1) |
|
>4cm |
14 (24.1) |
7 (22.6) |
7 (25.9) |
|
NACT, n (%) |
|
|
|
0.240 |
No |
55 (94.8) |
28 (90.3) |
27 (100) |
|
Yes |
3 (5.2) |
3 (9.7) |
0 (0.0) |
|
Adjuvant therapy, n(%) |
Adjuvant therapy, n(%) |
|
|
0.506 |
No |
5 (8.6) |
3 (9.7) |
2 (7.4) |
|
Chemotherapy |
37 (63.8) |
17 (54.8) |
20 (74.1) |
|
Radiotherapy |
13 (22.4) |
9 (29) |
4 (14.8) |
|
Both |
3 (5.2) |
2 (6.5) |
1 (3.7) |
|
Chemotherapy, n (%) |
Chemotherapy, n (%) |
|
|
0.704 |
Non |
8 (13.8) |
5 (16.1) |
3 (11.1) |
|
Non etoposide + platinum |
31 (53.4) |
15 (48.4) |
16 (59.3) |
|
etoposide + platinum |
19 (32.8) |
11 (35.5) |
8 (29.6) |
|
Radiotherapy,n (%) |
Radiotherapy,n (%) |
|
|
0.268 |
No |
17 (29.3) |
11 (35.5) |
6 (22.2) |
|
Yes |
41 (70.7) |
20 (64.5) |
21 (77.8) |
|
Gravidity, n (%) |
|
|
|
0.134 |
≤3 |
36 (62.1) |
22 (71.0) |
14 (51.9) |
|
>4 |
22 (37.9) |
9 (29.0) |
13 (48.1) |
|
Parity, n (%) |
|
|
|
0.712 |
≤2 |
50 (86.2) |
26 (83.9) |
24 (88.9) |
|
>3 |
8 (13.8) |
5 (16.1) |
3 (11.1) |
|
Diabetes, n (%) |
Diabetes, n (%) |
|
|
1 |
No |
53 (91.4) |
28 (90.3) |
25 (92.6) |
|
Yes |
5 (8.6) |
3 (9.7) |
2 (7.4) |
|
Hypertension, n (%) |
Hypertension, n (%) |
|
|
1 |
No |
51 (87.9) |
27 (87.1) |
24 (88.9) |
|
Yes |
7 (12.1) |
4 (12.9) |
3 (11.1) |
|
Family history, n (%) |
|
|
|
0.712 |
No |
50 (86.2) |
26 (83.9) |
24 (88.9) |
|
Yes |
8 (13.8) |
5 (16.1) |
3 (11.1) |
|
Time of operation,
(Mean ± SD)
|
192.9 ± 56.4
|
196.6 ± 48.7
|
188.7 ± 64.8
|
0.6
|
Type of operation, n (%) |
Type of operation, n (%) |
|
|
0.565 |
Laparoscopic surgery |
33 (56.9) |
16 (51.6) |
17 (63.0) |
|
Robotic surgery |
18 (31.0) |
10 (32.3) |
8 (29.6) |
|
Open surgery |
7 (12.1) |
5 (16.1) |
2 (7.4) |
|
Keep ovarian, n (%) |
Keep ovarian, n (%) |
|
|
0.864 |
No |
38 (65.5) |
20 (64.5) |
18 (66.7) |
|
Yes |
20 (34.5) |
11 (35.5) |
9 (33.3) |
|
Bleeding(ml), Mean ± SD |
167.4 ± 295.6 |
163.5 ± 191.8 |
171.9 ±
386.2 |
0.916 |
Lymph node metastasis, n (%) |
Lymph node metastasis, n (%) |
|
|
0.530 |
No |
41 (70.7) |
23 (74.2) |
18 (66.7) |
|
Yes |
17 (29.3) |
8 (25.8) |
9 (33.3) |
|
Perineural invasive, n (%) |
Perineural invasive, n (%) |
Perineural
invasive, n (%) |
|
1 |
No |
51 (87.9) |
27 (87.1) |
24 (88.9) |
|
Yes |
7 (12.1) |
4 (12.9) |
3 (11.1) |
|
LVSI, n (%) |
|
|
|
0.408 |
No |
31 (53.4) |
15 (48.4) |
16 (59.3) |
|
Yes |
27 (46.6) |
16 (51.6) |
11 (40.7) |
|
Uterus invasion, n (%) |
Uterus invasion, n (%) |
|
|
0.675 |
No |
52 (89.7) |
27 (87.1) |
25 (92.6) |
|
Yes |
6 (10.3) |
4 (12.9) |
2 (7.4) |
|
Parametrium invasion, n (%) |
Parametrium invasion, n (%) |
Parametrium invasion, n (%) |
|
0.116 |
No |
54 (93.1) |
27 (87.1) |
27 (100) |
|
Yes |
4 (6.9) |
4 (12.9) |
0 (0.0) |
|
Surgical margins, n (%) |
Surgical margins, n (%) |
Surgical margins,
n (%) |
|
0.494 |
No |
56 (96.6) |
29 (93.5) |
27 (100) |
|
Yes |
2 (3.4) |
2 (6.5) |
0 (0.0) |
|
Depth of stromal invasion, n (%) |
Depth of stromal invasion, n (%) |
Depth of stromal invasion, n (%) |
|
0.788 |
≤1/3 |
12 (20.7) |
6 (19.4) |
6 (22.2) |
|
>2/3 |
46 (79.3) |
25 (80.6) |
21 (77.8) |
|